The Latest Cardiac and Vascular News
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its fourth quarter and full year 2021 financial results on Tuesday, February 15, 2022. AtriCure will host a […]
WILMINGTON, Del., January 24, 2022 – Eplontersen has been granted Orphan Drug Designation (ODD) in the US by the Food and Drug Administration (FDA) for the treatment of transthyretin-mediated amyloidosis, a systemic, progressive and fatal condition. Eplontersen, formerly known as IONIS-TTR-LRx, is a ligand-conjugated antisense (LICA) investigational medicine currently in […]
SOUTH SAN FRANCISCO, Calif., Jan. 24, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its fourth annual Communications Fellowship Grant program, intended to support increased capacity in communications, awareness building and community engagement for nonprofit organizations serving the patient community. Five grants in the amount […]
Fourth-quarter highlights Group sales amounted to EUR 4.9 billion, with a 10% comparable sales decline Comparable order intake increased 4%, driven by double-digit growth in the Diagnosis & Treatment businesses Income from continuing operations amounted to EUR 139 million and included an impact of EUR 220 million related to the […]
Bloomington, Ind. — Cook Medical has received Breakthrough Device designation from the US Food and Drug Administration (FDA) on a new drug-eluting stent for below the knee (BTK). This new stent is designed to treat patients suffering from chronic limb-threatening ischemia (CLTI). “CLTI is a debilitating disease of growing prevalence around […]
Ghent, Belgium – 21 January 2022 – Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces in accordance with Article 15 of the Belgian Act of 2 May 2007 on […]
Oak Ridge, TN, Jan. 21, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announced today that it has appointed Caleb DesRosiers, JD, MPA to its Board of Directors, effective January 18, 2022. Mr. DesRosiers is currently a Senior Principal at Valuate Healthcare Consultancy, a leading […]
Hypertension Plus in the U.K., VitalSight™ in the U.S., Recognized as Outstanding Health Technology at World’s Largest Innovation Show HOOFDDORP, Netherlands–(BUSINESS WIRE)–OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal health technology, spotlighted its new remote patient monitoring services at the 2022 Consumer Electronics Show (CES) and […]
Casana’s Series B led by Morningside. Matrix Partners and Series A investors General Catalyst and Outsiders Fund join the round. The Heart Seat, an effortless, patient-centered health monitoring technology built into a toilet seat, is Casana’s first product. ROCHESTER, N.Y., Jan. 21, 2022 (GLOBE NEWSWIRE) — Casana, a healthcare technology […]
– Vutrisiran Met All 18 Month Secondary Endpoints, Including Statistically Significant Improvements in Neuropathy Impairment, Quality of Life (QoL), Gait Speed, Nutritional Status and Overall Disability, Relative to External Placebo – – Vutrisiran Continued to Demonstrate Halting or Reversal of Polyneuropathy, with Improvements in Neuropathy Impairment and QoL Relative to […]
